Risk–benefit balance of blood cultures among patients with stage IV cancer in unplanned admission: a nationwide propensity score–weighted study in Japan
BCs were associated with reduced mortality in patients with stage IV cancer, particularly those with immunosuppression. These findings may support personalized decision-making and resource allocation.
Authors
- Norihiko Inoue (ORCID: https://orcid.org/0000-0001-9187-371X)
- Shinobu Imai (ORCID: https://orcid.org/0000-0003-1784-5133)
- Takuaki Tani (ORCID: https://orcid.org/0000-0002-0798-524X)
- Yuki Hashimoto (ORCID: https://orcid.org/0000-0003-0629-0814)
Institutions
- SHOWA Medical University (JP)
- Tokyo Medical Center (JP)
- Showa Pharmaceutical University (JP)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-09-12
- DOI
- https://doi.org/10.1093/jac/dkaf368
- Citations
- 1
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Pfizer
- Pfizer Health Research Foundation
- Japan Society for the Promotion of Science